Genetic
YOLT-203
YOLT-203 is a genetic therapy with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_2
1
33%
Ph early_phase_1
2
67%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Active, not recruiting1
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Early Phase 12 (66.7%)
Phase 21 (33.3%)
Trials by Status
active_not_recruiting133%
not_yet_recruiting133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
not_yet_recruitingphase_2
Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)
NCT07587021
recruitingearly_phase_1
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
NCT06511349
active_not_recruitingearly_phase_1
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
NCT06892301
Clinical Trials (3)
Showing 3 of 3 trials
NCT07587021Phase 2
Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)
NCT06511349Early Phase 1
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
NCT06892301Early Phase 1
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
All 3 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 3